Nakae I, Quan L, Hashimoto K, Sugimoto Y, Tsutamoto T, Kinoshita M
First Department of Internal Medicine, Shiga University of Medical Science, Ohtsu, Japan.
Cardiovasc Drugs Ther. 1994 Feb;8(1):137-45. doi: 10.1007/BF00877102.
Nicorandil possesses hybrid properties as a nitrate and a potassium (K) channel opener. We have previously reported that large coronary arteries responded to nicorandil at low plasma concentrations, while dilatation of small coronary arteries only occurred at higher plasma concentrations (above 200 ng/ml) in chronically instrumented dogs. In this study we examined the effects of intravenous nicorandil on epicardial coronary artery diameter (CoD) and coronary blood flow (CBF) in the absence and presence of glibenclamide, a K+ channel blocker, as well as the effects of nitroglycerin and cromakalim as reference drugs. The increase in CBF induced by nicorandil and cromakalim was significantly suppressed by glibenclamide. However, the increase in CoD induced by nicorandil and nitroglycerin was not suppressed by glibenclamide. These findings suggest that nicorandil-induced dilatation of the large coronary arteries was related to its nitrate action, while nicorandil-induced dilatation of the small coronary arteries was closely related to its effect as a K+ channel opener. In addition, the former response to nicorandil occurred at low concentrations, while the latter occurred at higher concentrations.
尼可地尔兼具硝酸盐和钾(K)通道开放剂的特性。我们之前报道过,在长期植入仪器的犬类中,大冠状动脉在低血浆浓度时对尼可地尔有反应,而小冠状动脉的扩张仅在较高血浆浓度(高于200 ng/ml)时才会出现。在本研究中,我们检测了静脉注射尼可地尔在有无格列本脲(一种K⁺通道阻滞剂)存在的情况下对心外膜冠状动脉直径(CoD)和冠状动脉血流量(CBF)的影响,以及硝酸甘油和克罗卡林作为对照药物的影响。格列本脲显著抑制了尼可地尔和克罗卡林诱导的CBF增加。然而,格列本脲并未抑制尼可地尔和硝酸甘油诱导的CoD增加。这些发现表明,尼可地尔诱导的大冠状动脉扩张与其硝酸盐作用有关,而尼可地尔诱导的小冠状动脉扩张与其作为K⁺通道开放剂的作用密切相关。此外,对尼可地尔的前一种反应在低浓度时出现,而后者在较高浓度时出现。